Streetbeat News

WUXIF

Wuxi AppTec Co. Ltd.

http://www.wuxiapptec.com.cn/

CEO

Ge Li

Industry

Testing Laboratories

Open

6.16

Mkt cap

22B

Volume

High

6.16

P/E Ratio

9.95

52-wk high

12.69

Low

3.78

Div yield

0.04

52-wk low

3.74

Goldman Sachs highlights a significant opportunity in the biotech sector for outsourcing the production of obesity therapeutics, projecting the global obesity market to reach $100 billion by 2030, potentially expanding up to $400 billion. Novo Nordisk and Eli Lilly, current leaders in the market, are expected to outsource 50% of their production to meet demand, creating a $5 billion opportunity for outsourced providers. Seven biotech stocks, including Avantor, Thermo Fisher, Waters Corp., Agilent Technologies, Danaher, Wuxi AppTec, and Asymchem Laboratories, are identified as beneficiaries of this trend.

Portfolio Pulse from Piero Cingari

March 13, 2024 | 4:35 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.